Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
08156 SINOPHARM TECH
RT Nominal unchange0.098 0.000 (0.000%)
Latest  |  Final  |  Interim
Non-current Assets
2023/12 - Interim
HKD(K$)
%Chg
(Compare to Final)
2023/06
HKD(K$)
2022/06
HKD(K$)
2021/06
HKD(K$)
2020/06
HKD(K$)
Investment Properties0--0000
Property, plant, equip. & others917-21.152%1,1633,85017,11616,388
Land & other Lease Assets0--08009,51914,742
Intangible Assets3,337--0012,33246,180
Interests in Asso. & JCEs0--023,62145,66342,075
Other Non-current Assets5,2740.000%5,2745371,6306,686

9,52848.019%6,43728,80886,260126,071
Current Assets
2023/12 - Interim
HKD(K$)
%Chg
(Compare to Final)
2023/06
HKD(K$)
2022/06
HKD(K$)
2021/06
HKD(K$)
2020/06
HKD(K$)
Inventories6,044606.901%8556824,7457,459
Trade Receivables22,153173.663%8,09528,41914,31422,376
Cash & Bank Balances8,505378.885%1,7762,9917,4826,746
Other Current Assets0--16,31915,98623,10225,521
Assets Held for Sale0--0000

36,70235.707%27,04548,07849,64362,102
Current Liabilities
2023/12 - Interim
HKD(K$)
%Chg
(Compare to Final)
2023/06
HKD(K$)
2022/06
HKD(K$)
2021/06
HKD(K$)
2020/06
HKD(K$)
Trade Payables29,642-15.144%34,93254,58941,51333,607
S-T Debt & Leases10,000--045,929104,451109,660
Other Current Liabilities189,0976.053%178,304149,765126,913110,531
Liab asso w/ Assets Held for Sale0--0000

228,7397.270%213,236250,283272,877253,798
Net Current Assets(192,037)3.140%(186,191)(202,205)(223,234)(191,696)
Total Assets Less Current Liabilities(182,509)1.533%(179,754)(173,397)(136,974)(65,625)
Non-current Liabilities
2023/12 - Interim
HKD(K$)
%Chg
(Compare to Final)
2023/06
HKD(K$)
2022/06
HKD(K$)
2021/06
HKD(K$)
2020/06
HKD(K$)
L-T Debt & Leases0--003,5827,760
Other Non-current Liabilities0--0000

0--003,5827,760
Capital and Reserves
2023/12 - Interim
HKD(K$)
%Chg
(Compare to Final)
2023/06
HKD(K$)
2022/06
HKD(K$)
2021/06
HKD(K$)
2020/06
HKD(K$)
  Share Capital57,4040.000%57,40456,72155,05053,621
  Reserves(233,728)1.560%(230,137)(223,498)(193,930)(126,701)
  Others0--0000
Shareholders' Funds(176,324)2.079%(172,733)(166,777)(138,880)(73,080)
Non-controlling Interests(6,185)-11.907%(7,021)(6,620)(1,676)(305)
Others0--0000

(182,509)1.533%(179,754)(173,397)(140,556)(73,385)
Commitments and Contingent Liabilities
2023/12 - Interim
HKD(K$)
%Chg
(Compare to Final)
2023/06
HKD(K$)
2022/06
HKD(K$)
2021/06
HKD(K$)
2020/06
HKD(K$)
Commitments----0001,540
Contingent Liabilities----0000
Remarks:  Real time quote last updated: 25/11/2024 10:58
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders ($)HKD -2,876,000
%Change--
EPS / (LPS)HKD -0.016
NBV Per Share ($)HKD -0.960
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.